Ultragenyx Pharmaceutical Inc.: RBC cuts to sector perform from outperform; cuts target price to $19 from $40
RARE•Related News
PBF Energy Announces Pricing Of $500 Million Of 0% Exchangeable Notes Due In 2032
PBF•
Impact Biomedical to execute 1-for-12.62 reverse stock split Sept. 23
IBO•
8x8 Director Andrew Burton disposes of USD 194,267.32 in common shares
EGHT•
BKV Corporation <BKV.N>: Gerdes Energy Research Raises to Buy From Neutral; Raises Price Target by $1 to $29
BKV•
Governments worldwide are way behind on AI, says Bill Gates
QQQ•